Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2026)
Scinai Immunotherapeutics (SCNI) posted Change in Receivables of -$22000.0 for Q1 2026, up 68.57% sequentially from -$70000.0 in Q2 2025, and down 146.81% YoY from $47000.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Change in Receivables for 8 years, with the latest figure at -$22000.0 in Q1 2026.
- Quarterly Change in Receivables fell 146.81% year-over-year to -$22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378000.0 (down 15.95% YoY) and the FY2025 annual result came in at -$43000.0, up 80.8% from the prior year.
- Change in Receivables improved to -$22000.0 in Q1 2026 per SCNI's latest filing, from -$70000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $372000.0 in Q4 2023 and troughed at -$333000.0 in Q4 2024.
- A 4-year average of $1909.1 and a median of -$22000.0 in 2026 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 98.89% in 2024, down 189.52% in 2024.
- Over 4 years, Change in Receivables stood at $372000.0 in 2023, then slumped by 189.52% to -$333000.0 in 2024, then surged by 78.98% to -$70000.0 in 2025, then soared by 68.57% to -$22000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$22000.0, -$70000.0, and $47000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | -333,000.00 |
| Dec 31, 2024 | -333,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Jun 30, 2023 | -132,000.00 |
| Jun 30, 2023 | -132,000.00 |